ScholarLens Back to search
2002•Journal watchRequires access

Long-Term and Cardiac Safety Profile of Tegaserod

Douglas K. Rex

Open publisher page 0 citations

Abstract

Cisapride -- a gastrointestinal prokinetic agent with mixed 5-hydroxytryptamine-3 (5-HT3) antagonist and 5-HT4 agonist activity -- was withdrawn from

About this research paper

What this paper is about

Cisapride -- a gastrointestinal prokinetic agent with mixed 5-hydroxytryptamine-3 (5-HT3) antagonist and 5-HT4 agonist activity -- was withdrawn from

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Cisapride -- a gastrointestinal prokinetic agent with mixed 5-hydroxytryptamine-3 (5-HT3) antagonist and 5-HT4 agonist activity -- was withdrawn from

Key concepts: Tegaserod, Medicine, Term (time), Safety profile, Intensive care medicine, Cardiology, Internal medicine, Adverse effect

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Long-Term and Cardiac Safety Profile of Tegaserod — Research Paper | ScholarLens